where to get fda approved tirzepatide What Is Compounded Tirzepatide? Safety Guide 2026 FDA approves new obesity drug

As supply began to normalize, FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, and provided phased enforcement grace periods for compounders to wind down operations

Safety and Protocols Peptide stacks for fertility optimization need an established safety architecture prior to any dosing or stacking

Availability Due to the surge in demand, some GLP-1s have been in short supply over the past several months, as you may have seen reported in the news

Provided for prescriber reference

Weight-loss injections, such as Wegovy and Mounjaro, have transformed how we treat obesity